Cedal Nano proudly announces the production and launch of Ifosfamide under the brand name IfoCedal®️ for the first time in Iran. This innovative chemotherapy drug is designed with advanced, secure packaging that significantly reduces healthcare workers’ exposure to cytotoxic materials, ensuring a safer handling process.

IfoCedal®️ is a critical treatment for various malignancies, including lung cancer, ovarian cancer, and lymphoma. The introduction of this drug represents a major milestone in improving access to high-quality oncology treatments for patients across the country.

By integrating cutting-edge technology and adhering to global standards, Cedal Nano has set a new benchmark for effective and safe cancer treatments, reinforcing its commitment to both patient care and the healthcare workforce.

We”fosfamide, beyond “I”fosfamide – Ifocedal®️